DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution

Thursday, 27 August 2015

Pinacolone

Pinacolone

340
NamePinacolone
Synonyms3,3-Dimethylbutanone
Name in Chemical Abstracts3,3-Dimethyl-2-butanon
CAS No75-97-8
EINECS No200-920-4
Molecular formulaC6H12O
Molecular mass100.16
SMILES codeCC(C)(C)C(=O)C

1H-NMR


















1H NMR

1H-NMR: Pinacolone
250 MHz, CDCl3
delta [ppm]mult.atomsassignment
1.12s9 HCH3 tert-butyl
2.12s3 HCH3-C(=O)-





Pinacol pinacolone rearrangement

Reaction type: pinacol rearrangement, Wagner-Meerwein rearrangement
Substance classes: alcohol, ketone
Techniques: simultaneous distillation / extraction (SDE), column distillation, stirring with magnetic stir bar, heating with oil bath
Degree of difficulty: Easy
Pinacol
H2SO4
reacts to

Pinacolone ; Side reactions

 

 

 

13C-NMR

3C-NMR: Pinacolone
62.5 MHz, CDCl3
delta [ppm]assignment
14.1CH3 ethyl
24.6C1
26.3C4, tert-butyl-CH3
44.3C3
214.3C2
76.5-77.5CDCl3
////////////////////////////////////////////
Operating scheme









IR
IR: Pinacolone
[ATR, T%, cm-1]
[cm-1]assignment
2969, 2874aliph. C-H valence
1705C=O valence, ketone
1355, 1365char. for tert-butyl

Substances required

Batch scale: 0.01 mol 0.1 mol Pinacol
Educts
Amount Risk Safety
Pinacol
Xi Xi
11.8 g R 38 S 37
Reagents
Amount Risk Safety
Sulfuric acid 24 percent
C C
50 mL R 35 S 1/2-26-30-45
Solvents
Amount Risk Safety
tert-Butyl methyl ether
F F Xi Xi
40 mL R 11-38 S 2-9-16-24
Solvents for analysis
Amount Risk Safety
tert-Butyl methyl ether
F F Xi Xi

R 11-38 S 2-9-16-24


Substances produced

Batch scale: 0.01 mol 0.1 mol Pinacol
Products
Amount Risk Safety
Pinacolone
F F Xn Xn
7.3 g R 11-22 S 16-20/21
Byproducts
Amount Risk Safety
2,3-Dimethylbut-3-en-2-ol


R no data S no data

Waste Disposal
acid aqueous phase (neutralize) solvent water mixtures, halogen free
distillation residues organic solvents, halogen free
distilled tert-butyl methyl ether solvents for rectification
sulfuric acid can be reused for this reaction about five times



Equipment

Batch scale: 0.01 mol 0.1 mol Pinacol
round bottom flask 100 mL round bottom flask 100 mL
round bottom flask 50 mL round bottom flask 50 mL
simultaneous distillation extraction (SDE) apparatus simultaneous distillation extraction (SDE) apparatus
heatable magnetic stirrer with magnetic stir bar heatable magnetic stirrer with magnetic stir bar
heatable magnetic stirrer with magnetic stir bar heatable magnetic stirrer with magnetic stir bar
Vigreux column Vigreux column
distillation apparatus distillation apparatus
oil bath oil bath
oil bath oil bath


procedure

http://kriemhild.uft.uni-bremen.de/nop/en/instructions/pdf/3028_en.pdf


 





LiteratureC. J. Collins,Quart. Rev.1960,14, 357
////////














Wednesday, 26 August 2015

Tetratopic pyrimidine–hydrazone ligands

.




The first tetratopic pyrimidine–hydrazone (pym–hyz) molecular strands containing terminal hydroxymethyl (L1) and acryloyl (L2) functional groups have been synthesised. L1 was produced by step-wise imine condensation reactions, starting with 6-hydroxymethyl-2-pyridinecarboxaldehyde. L2 was then synthesised through the treatment of L1 with acryloyl chloride. NMR spectroscopy and X-ray crystallography showed that the ligands adopted a helical shape, comprised of 1 and 1/3 helical turns. Both L1 and L2 uncoiled upon reaction with an excess amount of Pb(II), Zn(II) and Cu(II) ions, resulting in linear M4LA8 complexes (where M = Pb(II), Zn(II), or Cu(II); L = L1 or L2; and A = ClO4, SO3CF3 or BF4). Horse-shoe shaped Pb2LA4 complexes were also formed by reacting Pb(II) ions with either L1 or L2 in a 2 : 1 metal to ligand ratio. The addition of Ag(I) ions to either L1 or L2 resulted in Ag2L2A2 double helicates, which were stable in the presence of excess Ag(I). The Pb(II), Zn(II) and Ag(I) complexes were characterised by NMR spectroscopy, while UV-Vis spectroscopy was used to probe the Cu(II) complexes. In addition, X-ray crystallography was used to analyse the linear Pb4L1A8, horse-shoe shaped Pb2L1(ClO4)4, twisted Cu3L2(SO3CF3)6, and double helicate Ag2L12(SO3CF3)2 complexes yielding the structures [Pb4L1(ClO4)7(H2O)]ClO4·4CH3NO2 (1), [Pb4L1(SO3CF3)8]2·6CH3CN·H2O (2), [Pb2L1(ClO4)2(CH3CN)(H2O)](ClO4)2·2CH3CN·C4H10O·H2O (3), [Cu3L2(SO3CF3)3(CH3CN)2(H2O)](SO3CF3)3·2CH3CN·H2O (4) and [Ag2L12](SO3CF3)2·CH3CN·H2O (5), respectively.


Graphical abstract: Tetratopic pyrimidine–hydrazone ligands modified with terminal hydroxymethyl and acryloyl arms and their Pb(ii), Zn(ii), Cu(ii) and Ag(i) complexes 
 
 

Tetratopic pyrimidine–hydrazone ligands modified with terminal hydroxymethyl and acryloyl arms and their Pb(II), Zn(II), Cu(II) and Ag(I) complexes

*Corresponding authors
aDepartment of Chemistry, University of Otago, PO Box 56, Dunedin, New Zealand
E-mail: lhanton@chemistry.otago.ac.nz
Dalton Trans., 2014,43, 8205-8218

DOI: 10.1039/C3DT53559B

// http://pubs.rsc.org/en/content/articlelanding/2014/dt/c3dt53559b#!divAbstract

Two new ent-kaurane diterpenoids from Albizia mollis (Wall.) Boiv

.


Mollisside A (1) was isolated as white powder. Its molecular formula was determined to be C26H44O8 with five unsaturation degrees by HRFABMS (m/z 483.2959 [M-1]-) and 13C NMR spectra. The 1H NMR spectrum of compound 1 clearly showed signals to three methyls at δ 0.83 (3H, s), 1.03 (3H, s), 1.07 (3H, s), and one anomeric hydrogen of β-type sugar at δ 4.30 (1H, d, J 7.8 Hz). The 13C NMR ({1H} and DEPT) spectroscopic data (Table 1) revealed the presence of 3 methyls, 10 methylenes, 9 methines and 4 quaternary carbons. Carbon signals at δ 106.8 (d), 75.6 (d), 77.7 (d), 71.6 (d), 78.2 (d), 62.8 (t) suggested the presence of one glucose, which were further confirmed by its MS fragmentation peaks at m/z 323 [M-1-160 = C6H8O5 formed by fragmentation involving glc moiety C6H10O5]- and the acid hydrolysis of 1. Comparison of these NMR data with those similar data reported in the literature13 showed that compound 1 had the same ent-kaurane skeleton. The linkage of glucose moiety to C-3 was determined by the HMBC correlations from H-1' (δ 4.30), H-18 (δ 1.03) and H-19 (δ 0.83) to C-3 (δ 90.9) (Figure 2). The attachment of one hydroxyl at C-17 in 1 was established by HMQC and HMBC spectra revealing correlations of H-17 (δ 3.27) with C-16 (δ 80.7), C-13 (δ 42.3) and C-15 (δ 53.1). Besides, the relative configuration of 1 was elucidated by a ROESY experiment and by comparison of the NMR data with those reported in the literature.14 The key ROESY correlations of H-3/H-18, H-3/H-5 and H-9/H-5 (Figure 3), indicated α-orientation of C-3 glycoside and β-orientations of H-5 and H-9. The α-orientation of CH2OH-17 (δc 70.6) in 1 was elucidated by comparison of the 13C NMR data with those reported δc 69.8 for α-orientation and δc 66.2 for β-orientation at C-17.14 Based on the above evidences, compound 1 was identified as 3α, 16β, 17-trihydroxy-ent-kaurane 3-O-β-D- glucopyranoside, named Mollisside A.
 http://www.scielo.br/img/revistas/jbchs/v21n9/a25fig01m.gif

Mollisside B (2) was determined to have a molecular formula C26H40O9 on the basis of the positive HRFABMS (m/z 519.2565 [M+Na]+) and 13C NMR (DEPT) spectra, which possessed seven unsaturation degrees. Its IR spectrum showed a broad band (3518-2930 cm-1) and absorption 1691 cm-1 for a carboxyl and 1607 cm-1 for a double bond. The 1H NMR spectrum of compound 2 exhibited three methyls at δ 0.88 (3H, s), 1.12 (3H, s), 1.16 (3H, s), one anomeric proton of β-type sugar at δ 4.32 (1H, d, J 7.8 Hz) and one olefinic proton at δ 6.48 (1H, s). The 13C NMR spectroscopic data (Table 1) revealed 26 carbon atoms, including one carboxyl (C-17 at δ 164.1) and two olefinic carbons (C-16 at δ 139.9, C-15 at δ 154.7). Comparison of these NMR data with mollisside A showed that compound 2 had the similar skeleton of compound 1 except for the distinct differences of chemical shift of C-2 (δ 68.1) adjacent one oxygenated group and C-17, C-15 and C-16 conforming the α,β-unsaturation ketone system. The linkage of the glucose moietiy to C-3 (δ 96.1) was determined by the HMBC correlations from H-1' (δ 4.32), H-18 (δ 1.12) and H-19 (δ 0.88) to C-3 (Figure 2). Besides, the relative configuration of 2 was elucidated by a ROESY experiment and by comparison of the NMR data with 1. The α-orientation of H-2 was established by key ROESY correlations of H-2/H-1α, H-2/H-19 and H-2/H-20 (Figure 3) and the coupling constant J 9.3 Hz observed in the signal corresponding to H-3 (interaction axial- axial with H-2). Moreover, the β-orientations of H-3, H-5 and H-9 were confirmed by ROESY between H-3/H-5, H-3/H-18 and H-5/H-9. Based on the above evidences, the structure of 2 was elucidated as 2β,3α-dihydroxy-ent-kaur-15-en-17-oic acid 3-O-β-D-glucopyranoside, named Mollisside B.


Mollisside A
White powder, mp 292-294 ºC; [α]D21 +6.3116 (c 0.101, CH3OH); UV (CH3OH) λmax/nm (log ε): 193(3.587), 205 (3.829), 277 (3.250); IR (KBr) νmax/cm-1: 3420, 2937, 1166, 1074, 1020; 1H NMR (400 MHz, CD3OD) and 13C NMR (100 MHz, CD3OD) see Table 1; HRESIMS (negative ion) m/z 483.2959 [M-1]- (Calc. for C26H44O8, 483.2957); FABMS (negative ion) m/z(%) 483[M-1]- (100), 391 (5), 323 (15), 282 (5), 159 (6), 113 (5).
Mollisside B
White powder, mp 270-271 ºC; [α]D21 -1.5989 (c 0.246, CH3OH); UV (CH3OH) λmax/nm (log ε): 196 (3.393), 203 (4.108), 276 (2.890); IR (KBr) νmax/cm-1: 3518, 3380, 3190, 2980, 2930, 1691, 1607, 1073, 1037; 1H NMR (500 MHz, CD3OD) and 13C NMR (125 MHz, CD3OD) see Table 1; HRESIMS (positive ion) m/z 519.2565 [M+Na]+ (Calc. for C26H40O9Na, 519.2570); FABMS (negative ion) m/z(%): 495[M-1]- (100), 400 (5), 335 (5), 281(6), 123 (4).



































ABSTRACT
Two new kaurane diterpenoids, 3α, 16β, 17-trihydroxy-ent-kaurane 3-O-β-D-glucopyranoside and 2β,3α-dihydroxy-ent-kaur-15-en-17-oic acid 3-O-β-D-glucopyranoside, were isolated from the bark of Albizia mollis (Wall.) Boiv. The structures of two new compounds were elucidated by extensive 1D- and 2D-NMR spectroscopic methods in combination with MS experiments.

Journal of the Brazilian Chemical Society

Print version ISSN 0103-5053

J. Braz. Chem. Soc. vol.21 no.9 SĂŁo Paulo  2010

http://dx.doi.org/10.1590/S0103-50532010000900025 


Two new ent-kaurane diterpenoids from Albizia mollis (Wall.) Boiv


Zhong-Quan ChengI,II; Dan YangI; Yu-Qing LiuI; Jiang-Miao HuI; He-Zhong JiangI; Peng-Cheng WangI; Ning LiIII; Jun ZhouI; You-Xing ZhaoI,*
IState Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, the Chinese Academy of Sciences, Kunming 650204, P. R. China
IIGraduate School of the Chinese Academy of Sciences, Beijing 100049, P. R. China
IIISchool of Life Sciences, Anhui University, Hefei 230039, P. R. China




Keywords: Albizia mollis, kaurane diterpenoids, mollisside A, mollisside B

////

Rapid structure determination of microgram-level drug metabolites using HPLC-MS, fraction collection and NMR spectroscopy

.


A robust method for in vitro metabolite generation and facile sample preparation on analytical HPLC was established for rapid structure determination of microgram-level drug metabolites by using high-field NMR equipped with a cryoprobe. A single 1–5 mL incubation of drug candidate (10–30 ÎĽM) in microsomes, hepatocytes, or recombinant drug-metabolising enzymes, typically cytochrome P450s and UDP-glucuronosyltransferases, was used for metabolite formation. Following precipitation of proteins and solvent removal, metabolite mixtures were chromatographed with 5–10 injections onto an HPLC-MS system. Metabolites were collected into a 96-well plate, dried, and reconstituted in deuterated NMR solvents. NMR spectra of isolated metabolites were acquired on a 500 MHz spectrometer equipped with a 5 mm cryogenic probe. The methodology has been successfully employed as an extension of HPLC-MS/MS-based metabolite identification and applied frequently to 0.5–10 ÎĽg quantities of metabolite. Most structure determinations were achieved rapidly by 1D 1H NMR with satisfactory signal-to-noise ratios, whereas some required 2D NMR data analysis. This report describes the method development and metabolite structure determination using the model compound trazodone. In addition to trazodone, a large number of examples from our laboratories have proven that the microgram-level NMR method avoids time-consuming preparative-scale metabolite generation and purification and circumvents technical complications associated with online LC-NMR. Most importantly, the turnaround time of metabolite structure determination for metabolically unstable compounds using the present methodology is more in sync with the cycle time during which medicinal chemists modify metabolic softspots while performing other iterative lead optimisation activities, demonstrating a real impact on the drug-discovery process.


Graphical abstract: Rapid structure determination of microgram-level drug metabolites using HPLC-MS, fraction collection and NMR spectroscopy





Rapid structure determination of microgram-level drug metabolites using HPLC-MS, fraction collection and NMR spectroscopy

*Corresponding authors
aPharmaceutical Candidate Optimization, Bristol-Myers Squibb Research & Development, 5 Research Parkway, Wallingford, USA
E-mail: yuezhong.shu@bms.com
Anal. Methods, 2010,2, 1542-1549

DOI: 10.1039/C0AY00290A
 http://pubs.rsc.org/en/content/articlelanding/2010/ay/c0ay00290a/unauth#!divAbstract






///////